Zdrowie i gospodarka · 11/07/2016

FDA Requests Public Comment on Proposed Collection of Biologics Information

The Food and Drug Administration is seeking public input on proposed changes to its licensing procedures for biologics, including labeling and postmarketing studies, as part of its effort to streamline regulatory processes.